Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.050
+0.130 (6.77%)
At close: Jun 6, 2025, 4:00 PM
2.130
+0.080 (3.90%)
After-hours: Jun 6, 2025, 4:58 PM EDT
Celularity Employees
Celularity had 123 employees as of December 31, 2024. The number of employees increased by 3 or 2.50% compared to the previous year.
Employees
123
Change (1Y)
3
Growth (1Y)
2.50%
Revenue / Employee
$440,813
Profits / Employee
-$470,667
Market Cap
49.81M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 123 | 3 | 2.50% |
Dec 31, 2023 | 120 | -105 | -46.67% |
Dec 31, 2022 | 225 | 0 | - |
Dec 31, 2021 | 225 | 63 | 38.89% |
Dec 31, 2020 | 162 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CELU News
- 5 days ago - Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology - GlobeNewsWire
- 8 days ago - Celularity Receives Nasdaq Notice Regarding Form 10-Q - GlobeNewsWire
- 4 weeks ago - Celularity Announces Full Year 2024 Operating and Financial Results - GlobeNewsWire
- 6 weeks ago - Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees - GlobeNewsWire
- 7 weeks ago - Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - GlobeNewsWire
- 3 months ago - Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products - GlobeNewsWire
- 3 months ago - Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company - GlobeNewsWire
- 6 months ago - Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - GlobeNewsWire